{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}],"title":"AA"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"AG"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"CC"},{"measurements":[{"groupId":"OG000","value":"2"}],"title":"GG"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"TC"},{"measurements":[{"groupId":"OG000","value":"2"}],"title":"TG"},{"measurements":[{"groupId":"OG000","value":"13"}],"title":"TT"}],"title":"Genetic Polymorphisms for monoamine oxidase A (MAOA) rs6323"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}],"title":"AA"},{"measurements":[{"groupId":"OG000","value":"7"}],"title":"AG"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"CC"},{"measurements":[{"groupId":"OG000","value":"5"}],"title":"GG"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"TC"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"TG"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"TT"}],"title":"Genetic Polymorphisms for catecholamine-O-methyltransferase (COMT) rs4680"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}],"title":"AA"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"AG"},{"measurements":[{"groupId":"OG000","value":"6"}],"title":"CC"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"GG"},{"measurements":[{"groupId":"OG000","value":"4"}],"title":"TC"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"TG"},{"measurements":[{"groupId":"OG000","value":"7"}],"title":"TT"}],"title":"Genetic Polymorphisms for dopamine receptor D (DRD3) rs6280"}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"description":"Frequencies of genetic polymorphisms were reported.","groups":[{"description":"Patients with neurotransmitter studies","id":"OG000","title":"Patients With Neurotransmitter Studies"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Eligible patients who had neurotransmitter studies performed. Seventeen patients had studies performed.","reportingStatus":"POSTED","timeFrame":"At study enrollment (Day 0)","title":"Pharmacogenetic Variation on Central Nervous System Transmitters","type":"SECONDARY","unitOfMeasure":"Participants"}